Researchers sought to examine the prevalence of self-reported cannabis use and its association with postoperative pain among ...

The sensitivity, specificity, and accuracy of clinical guidelines for managing GIO varied across several countries and organizations.

Among patients with RA, ACPA status significantly modifies the relationship between BMI and cardiovascular risk.

The FDA has approved Nuvaxovid to prevent COVID-19 in adults 65 years and older and high-risk individuals 12 through 64 years.

Exposure to air pollution may worsen bone loss in postmenopausal women, according to study results published in the Journal of Bone and Mineral Research.

There is no association between COVID-19 vaccination in pregnancy and spontaneous abortion, according to study findings.

The FDA has approved Brekiya (dihydroergotamine mesylate) injection for the acute treatment of migraine with or without aura and the acute treatment of cluster headaches in adults.

The FDA granted Priority Review to lenacapavir for the prevention of HIV as pre-exposure prophylaxis (PrEP). Lenacapavir is a long-acting HIV-1 capsid inhibitor administered as a twice-yearly ...

HealthDay News — Preinjury mobility data predicts recovery following a lower-extremity fracture in adults, according to a proof-of-concept study published online April 28 in the Journal of Bone & ...

Gabapentinoids are not associated with risk for self-harm in adults; however, elevated risk is seen before initiation of treatment, during the initial phase of treatment, and after discontinuation of ...

Illicit opioid use may be higher than previously reported in the United States, according to a study published online May 9 in JAMA Health Forum. David Powell, ...

Drug overdose deaths in the United States decreased from an estimated 110,037 in 2023 to 80,391 in 2024. HealthDay News — Drug overdose deaths decreased by 26.9 percent from 2023 to 2024, according to ...